Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
A-Level Capital is a student-run venture capital firm founded in 2015 at Johns Hopkins University in Baltimore, Maryland. The firm focuses on empowering the entrepreneurial ecosystem at JHU by providing seed funding and support to startups founded by students and alumni. A-Level Capital has grown to a team of 47 members, including 23 partners, and manages total assets of approximately $2 million.
Since its inception, A-Level Capital has made over 57 investments, primarily in early-stage companies. The firm has achieved notable milestones, including two unicorn exits: Elemy, valued at $1.15 billion, and In Silico, which is expected to go public in Hong Kong with a valuation of $1.72 billion. The firm’s unique position within the JHU ecosystem allows it to leverage academic resources and innovation to support its portfolio companies.
A-Level Capital invests primarily in seed-stage startups, focusing on companies founded by Johns Hopkins University alumni and affiliates. The firm targets sectors such as SaaS, healthcare, biotech, and artificial intelligence. Typical check sizes range from $100,000 to $5 million, with a strong emphasis on providing capital for the first 6 to 18 months of a startup's journey. This funding is crucial for preparing companies for accelerators and subsequent funding rounds.
The firm has a dedicated focus on medical and technology sectors, aligning its investments with the strengths of Johns Hopkins. A-Level Capital also engages in follow-on funding, providing introductions to limited partners for additional fundraising opportunities. Their investment strategy is designed to empower the JHU entrepreneurial ecosystem by supporting startups that demonstrate potential for growth and innovation.
A-Level Capital has built a diverse portfolio of 57 companies, with notable successes in various sectors. Key portfolio companies include:
This portfolio reflects A-Level Capital's commitment to investing in innovative companies that leverage technology to address pressing challenges in healthcare and other sectors.
Brock Manz - Managing Partner. Brock has extensive experience in venture capital and has led multiple successful investments in the technology sector.
Nadia Momtaz - Managing Partner. Nadia specializes in healthcare investments and has a strong background in medical technology.
Pratibha Pradeep - Managing Partner. Pratibha focuses on biotech investments and has a background in life sciences.
Rose Majeed - Managing Partner. Rose has experience in early-stage investing and works closely with portfolio companies to drive growth.
Julia Weinrod - Partner. Julia has a background in finance and supports startups in financial strategy and fundraising.
Zachary Sayyah - Partner. Zachary focuses on technology investments and has experience in software development.
Demi Obayomi - Founding Partner. Demi has been instrumental in establishing A-Level Capital and has a strong network within the JHU community.
Elizabeth Galbut - Founding Partner. Elizabeth has a background in entrepreneurship and supports startups in business development.
To pitch A-Level Capital, founders should submit their proposals through the firm's website at alevelcapital.com. The pitch deck should include an overview of the business, market analysis, financial projections, and information about the founding team. A-Level Capital prefers concise and well-structured presentations that clearly articulate the startup's vision and potential.
Founders are encouraged to provide any relevant metrics or traction data that can support their case. A-Level Capital typically reviews submissions and aims to respond within a few weeks.
On February 4, 2025, A-Level Capital made its latest investment, continuing its trend of supporting early-stage startups. Recent investments have included companies in enterprise software and AI workflows, reflecting the firm's commitment to innovation in technology.
Notable portfolio updates include Elemy, which achieved unicorn status with a valuation of $1.15 billion, and In Silico, which is preparing for an IPO in Hong Kong with a projected valuation of $1.72 billion. These exits highlight A-Level Capital's successful investment strategy and its focus on high-potential startups.
What are A-Level Capital's investment criteria?
A-Level Capital primarily invests in seed-stage startups founded by Johns Hopkins University students and alumni. The firm focuses on sectors such as SaaS, healthcare, biotech, and AI, with check sizes typically ranging from $100,000 to $5 million.
How can startups apply or pitch to A-Level Capital?
Startups can pitch to A-Level Capital through their website at alevelcapital.com. Founders should include a detailed business plan, financial projections, and information about their team in their pitch deck.
What makes A-Level Capital different from other VC firms?
A-Level Capital is unique as a student-run venture capital firm that specifically supports startups within the Johns Hopkins University ecosystem. This focus allows them to leverage academic resources and networks that are not typically available to other VC firms.
What is the geographic scope of A-Level Capital's investments?
The firm primarily invests in startups located in the United States and North America, particularly those connected to the Johns Hopkins community.
What kind of post-investment involvement does A-Level Capital have?
A-Level Capital provides ongoing support to its portfolio companies through access to a professional network of investors and advisors. They also facilitate introductions to limited partners for follow-on fundraising.
What is the typical response time for pitch submissions?
A-Level Capital aims to respond to pitch submissions within a few weeks, depending on the volume of applications received. Founders are encouraged to follow up if they do not receive a response within this timeframe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.